[Federal Register Volume 70, Number 87 (Friday, May 6, 2005)]
[Notices]
[Pages 24045-24046]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-9067]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-05-05BW]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-371-5983 or 
send comments to Seleda Perryman, CDC Assistant Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Survey of Primary Care Physicians Regarding Prostate Cancer 
Screening--New--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    Prostate cancer is the most common cancer in men and is the second 
leading cause of cancer deaths, behind lung cancer, in the United 
States. The American Cancer Society estimates that there will be about 
232,090 new cases of prostate cancer and about 30,350 deaths in 2005. 
Although prostate cancer deaths have declined over the past several 
years, it ranks fifth among deaths from all causes.
    The Digital Rectal Examination (DRE) and Prostate Specific Antigen 
(PSA) test are used to screen for prostate cancer. Screening is 
controversial and many are not in agreement as to whether the potential 
benefits of screening outweigh the risks, that is, if PSA based 
screening, early detection, and treatment increases longevity. Although 
major medical organizations are divided on whether men should be 
routinely screened for this disease, it appears that all of the major 
organizations recommend discussion with patients about the benefits and 
risks of screening.
    The purpose of this project is to develop and administer a national 
survey to a sample of American primary care physicians to examine 
whether or not they: (1) Screen for prostate cancer using PSA and/or 
DRE, (2) recommend testing and under what conditions, (3) discuss the 
tests and the risks and benefits of screening with patients, and

[[Page 24046]]

(4) use screening practices that vary by factors such as age, 
ethnicity, and family history of the patient. This study will also 
examine the demographic, social, and behavioral characteristics of 
physicians as they relate to screening of similar issues and 
participate in shared decision-making between the physician and the 
patient.
    There will be no cost to respondents other than their time.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
                   Respondents                       Number of     responses per   per response    Total burden
                                                    respondents     respondents     (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Primary Care Physician..........................           1,500               1           40/60           1,000
                                                 -----------------
    Total.......................................           1,500  ..............  ..............           1,000
----------------------------------------------------------------------------------------------------------------


    Dated: April 29, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 05-9067 Filed 5-5-05; 8:45 am]
BILLING CODE 4163-18-P